Related Experiment Video
Updated: Oct 7, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
The teratogenic effect of pregabalin on heart, liver and kidney in rats: a light microscopic, electron microscopic
Omnia I Ismail1, Eman S Shaltout2, Nora Z Abdellah2
1Department of Human Anatomy and Embryology, Faculty of Medicine, Assiut University, Assiut, 71515, Egypt. omnia.ismail@med.aun.edu.eg.
Insights
Pregabalin (PGB) shows dose-dependent embryotoxicity in rats. Higher PGB doses caused significant developmental toxicity, while lower doses had minimal effects.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Pregabalin (PGB) is an anti-epileptic drug with limited data on teratogenic effects.
- Understanding PGB's developmental toxicity is crucial for its safe use.
Purpose of the Study:
- To evaluate the developmental toxicity of Pregabalin (PGB) in a rat model.
- To assess the impact of PGB on fetal development and organ histology.
Main Methods:
- 60 pregnant albino rats were divided into three groups: control (no medication), PGB 500 mg/kg, and PGB 1250 mg/kg.
- Histological, immunohistochemical, and morphometric analyses were performed on pup liver, kidney, and heart specimens.
- Pups were examined for developmental abnormalities and organ damage.
Main Results:
- A PGB dose of 500 mg/kg resulted in minimal toxic effects, including mild collagen deposition and moderate caspase-3 expression.
- A PGB dose of 1250 mg/kg induced significant toxic effects: cardiac myofiber degeneration, ruptured blood vessels, renal cortex vacuolations, fibrosis, and strong caspase-3 expression.
- These findings indicate dose-dependent embryotoxicity.
Conclusions:
- Pregabalin (PGB) exhibits embryotoxicity in a dose-dependent manner.
- Higher doses of PGB lead to more pronounced degenerative changes in developing organs.
- Further research is warranted to fully elucidate the teratogenic potential of PGB.
Background:
Pregabalin (PGB) was approved as new anti-epileptic drugs with little information about its teratogenic effect.
Aim Of The Work:
to evaluate the developmental toxicity of PGB.
Materials And Methods:
60 pregnant albino rats were divided into three groups. PGB (500 mg/kg body weight/day) was given to group II, PGB (1250 mg/kg body weight/day) was given to Group III and no medications were given to group I. The pups were normally delivered. Liver, kidney and heart specimens were prepared for histological, immunohistochemical, and morphometric studies.
Results:
A dose of 500 mg of PGB had minimal toxic effects in the form of mild collagen deposition and moderate positive caspase-3 immunoexpression. PGB dose of 1250 mg/kg induced gross toxic effects in form of degenerated cardiac myofibres, ruptured blood vessels, vacuolations in the renal cortex, fibrosis and strong positive caspase-3 immunoexpression.
Conclusion:
PGB at dose of 500 mg/kg revealed minimal toxic changes. PGB cause embryotoxicity in a dose-dependent manner, as the higher dose induced more degenerative changes.
Related Concept Videos
Teratogenicity
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

